Advanced search
Publication Cover
The American Journal of Drug and Alcohol Abuse
Encompassing All Addictive Disorders
Volume 39, 2013 - Issue 5
Submit an article Journal homepage
1,300
Views
13
CrossRef citations to date
0
Altmetric
Research Article

A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment

Brittany Vasae BurdickDepartment of Psychiatry, University of Texas Southwestern Medical Center Dallas, TX 75390USA
, BA &
Bryon AdinoffDepartment of Psychiatry, University of Texas Southwestern Medical Center Dallas, TX 75390USA;VA North Texas Health Care System, Dallas VA Medical Center Dallas, TX 75216USACorrespondence[email protected]
, MD
Pages 291-297 | Received 29 Mar 2013, Accepted 29 May 2013, Published online: 22 Aug 2013

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Katerina Flora. (2019) A review of the factors affecting the course and outcome of the treatment of substance use disorders. Journal of Substance Use 24:2, pages 120-124.
Read now
Bas T.H. de Veen, Arnt F.A. Schellekens, Michel M.M. Verheij & Judith R. Homberg. (2017) Psilocybin for treating substance use disorders?. Expert Review of Neurotherapeutics 17:2, pages 203-212.
Read now

Articles from other publishers (11)

Mehjabeen Hossain, Suresh P. Sulochana, Katie E. Heath, Saif Mohammad Ishraq Bari, Parker Brewster, Jared Barnes, Azim Munivar, Glenn M. Walker, David A. Puleo & Thomas A. Werfel. (2023) Interval delivery of 5HT 2A agonists using multilayered polymer films . Journal of Biomedical Materials Research Part A 111:6, pages 790-800.
Crossref
Lukas A. Basedow & Sören Kuitunen‐Paul. (2022) Motives for the use of serotonergic psychedelics: A systematic review. Drug and Alcohol Review 41:6, pages 1391-1403.
Crossref
Sen Yao, Chuanzheng Wei, Hui Lin, Peng Zhang, Yuanyuan Liu, Youjin Deng, Qianhui Huang & Baogui Xie. (2022) Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in Gymnopilus dilepis Mushroom via Amino Acid Metabolism Pathways. Journal of Fungi 8:8, pages 870.
Crossref
Lea J. Mertens, Michael Koslowski, Felix Betzler, Ricarda Evens, Maria Gilles, Andrea Jungaberle, Henrik Jungaberle, Tomislav Majić, Andreas Ströhle, Max Wolff, Stefan Wellek & Gerhard Gründer. (2022) Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) – Rationale and study design. Neuroscience Applied 1, pages 100104.
Crossref
Peter Eischens & William Leigh Atherton. (2018) Psychedelic therapy as a complementary treatment approach for alcohol use disorders. Journal of Psychedelic Studies 2:1, pages 36-44.
Crossref
Paul J. Fletcher, Fiona D. Zeeb, Caleb J. Browne, Guy A. Higgins & Ashlie D. Soko. (2017) Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate. Psychopharmacology 234:5, pages 889-902.
Crossref
Rafael G. dos Santos, Flávia L. Osório, José Alexandre S. Crippa, Jordi Riba, Antônio W. Zuardi & Jaime E. C. Hallak. (2016) Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic Advances in Psychopharmacology 6:3, pages 193-213.
Crossref
Michael P. Bogenschutz & Matthew W. Johnson. (2016) Classic hallucinogens in the treatment of addictions. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, pages 250-258.
Crossref
Mitchell G. Spring, Rory D. Ostrow & Robert M. Hallock. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse 794 800 .
Filip Tyls, Tomas Palenicek & Jiri Horacek. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse 782 793 .
Michael P Bogenschutz, Alyssa A Forcehimes, Jessica A Pommy, Claire E Wilcox, PCR Barbosa & Rick J Strassman. (2015) Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology 29:3, pages 289-299.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.